Spray device applies stem-cell suspension to promote healing | Skin grafts to be tested against epidermolysys bullosa | Cytori to test intravenous burn therapy
April 12, 2017
Advanced Tissue SmartBrief
Your resource for current wound care information
Wound Care Update
Spray device applies stem-cell suspension to promote healing
Medical technology startup RenovaCare's SkinGun sprays a liquid suspension of patient stem cells on skin wounds and burns to speed healing and reduce complications. The company is planning clinical studies later this year in hopes of gaining FDA approval.
Newsweek (4/11) 
LinkedIn Twitter Facebook Google+ Email
Research, Technology & Innovation
Skin grafts to be tested against epidermolysys bullosa
In a clinical trial, 14-year-old John Dilgen will receive skin grafts containing collagen VII, a protein lacking in his skin as the result of the rare genetic disorder epidermolysys bullosa. The condition leaves his skin "so fragile that the slightest thing can cause a blister, tear or wound," he said.
Staten Island Advance (N.Y.) (4/7) 
LinkedIn Twitter Facebook Google+ Email
Cytori to test intravenous burn therapy
The FDA cleared the way for a pilot clinical trial to test intravenous delivery of Cytori Cell Therapy as adjunctive therapy for patients suffering from thermal burns affecting 20% to 50% of their body surface.
24/7 Wall St. (4/10) 
LinkedIn Twitter Facebook Google+ Email
Health Policy & Regulation
Primary care doctors ready to offer palliative care
There is a shortage of palliative care specialists, meaning palliative services may only be available to patients in a hospital or hospice setting, writes Dr. Glen Stream, president and board chair of Family Medicine for America's Health. Primary care physicians, who have long-term relationships with patients, are in a good position to provide basic palliative care, Stream writes.
Medical Economics (4/8) 
LinkedIn Twitter Facebook Google+ Email
Patients should control end-of-life care, Sebelius says
Patients should be directing end-of-life care, not the government or physicians, said former HHS Secretary Kathleen Sebelius, who as part of the Aspen Institute's Health Strategy Group spent 2016 studying end-of-life care. Sebelius said that Medicare and Medicaid payments for end-of-life care should not favor any particular setting and that while the government can help increase awareness of palliative care options, it should not be involved in decision-making.
The Kansas City Star (Mo.) (4/5) 
LinkedIn Twitter Facebook Google+ Email
CMS sets deadline for MIPS registration for group reporting this year
Groups of eligible clinicians who plan to use the CMS' Group Web Interface or administer the Consumer Assessment of Healthcare Providers and Systems to report performance data for the Merit-based Incentive Payment System this year are required to register by June 30. "Eligible clinicians who participate as a group will be assessed at a group level across all four MIPS performance categories," and one payment adjustment will be received for the group's performance, according to the CMS.
EHR Intelligence (4/4) 
LinkedIn Twitter Facebook Google+ Email
Other News
Learn more about ADVTIS:
Meet Our People | Placing an Order
Why Use Advanced Tissue | Home
One does not plan and then try to make circumstances fit those plans. One tries to make plans fit the circumstances.
George S. Patton,
military leader
LinkedIn Twitter Facebook Google+ Email
About Advanced Tissue
Advanced Tissue is a leading wound care supply company offering a comprehensive line of wound care products from virtually all manufacturers. We understand the many obstacles associated with effective wound treatment and use this insight to provide the efficient delivery of dressings to enable enhanced compliance and improved patient outcomes.
Contact Advanced Tissue
7003 Valley Ranch Drive
Little Rock, Arkansas 72223
Sign Up
SmartBrief offers 200+ newsletters
Subscriber Tools:
Contact Us:
Editor  -  Kathryn Doherty
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
© 1999-2017 SmartBrief, Inc.®
Privacy policy |  Legal Information